Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06577558 |
| Consolidated Lead Sponsor | Shanghai SIMR Biotechnology Co |
| Therapeutic Condition Cohort | Infectious Disease and Vaccines |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 240 participants (ESTIMATED) |
| Registered Start Date | 2024-09-10 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking University Third Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Sun Yat-sen University | Guangzhou, China | Open Hospital Dossier -> |
| The First Hospital of Hebei Medical University | Shijiazhuang, China | Open Hospital Dossier -> |
| Henan Provincial People's Hospital | Zhengzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.